All Stories

  1. Effect of thiazolidinediones compared to other antidiabetic medications on incident dementia in people with type 2 diabetes: A target trial emulation study
  2. Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan
  3. Factors Associated with Suboptimal Adherence to Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma—A Retrospective Cohort Study
  4. Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis
  5. Survival and Radiotherapy-Related Adverse Events in Patients Receiving Radiotherapy and Concurrent Metformin: A Systematic Review and Meta-Analysis of Randomised Controlled Trials and Cohort Studies
  6. Perceptions of patients and health care professionals on postoperative pain management: Key factors influencing persistent opioid use
  7. Examining variations in the prevalence of hazardous opioid prescribing across general practices in England: a cross-sectional study
  8. Mobile health applications for supporting self-management of oral systemic anticancer therapy in haematological malignancies: A systematic review of acceptability and efficacy
  9. The Efficacy of Digital Interventions on Adherence to Oral Systemic Anticancer Therapy Among Patients With Cancer: Systematic Review and Meta-Analysis
  10. The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis
  11. A Systematic Review of Potential Opioid Prescribing Safety Indicators
  12. Structured medication reviews: progress since 2020 and opportunities for improvement
  13. Interventions to reduce opioid use for patients with chronic non-cancer pain in primary care settings: A systematic review and meta-analysis
  14. Decoding behaviour change techniques in opioid deprescribing strategies following major surgery: a systematic review of interventions to reduce postoperative opioid use
  15. Interventions to reduce opioid use for patients with chronic non-cancer pain in primary care settings: a systematic review and meta-analysis
  16. Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels
  17. Development of prescribing indicators related to opioid-related harm in patients with chronic pain in primary care—a modified e-Delphi study
  18. Prevalence and determinants of chronic pain and persistent opioid use after surgery: A review of systematic reviews
  19. Longitudinal Trajectory of Opioid Prescribing and its Associated Serious Adverse Events: A Population‐Wide Cohort Study in Taiwan
  20. Risk of serious infection and infection mortality in patients with psoriasis: A nationwide cohort study using the Taiwan National Health Insurance claims database
  21. The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis
  22. Feasibility and validity of using healthcare databases to conduct cross‐national comparative studies of opioid use, its determinants and consequences
  23. Examining non-linearity in the association between age and reported opioid use in different socioeconomic strata: cohort study using Health Survey for England waves from 1997 to 2014
  24. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression
  25. Cohort Description: Preventing an Opioid Epidemic in Norway – Focusing on Treatment of Chronic Pain (POINT) – A National Registry-Based Study
  26. Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study
  27. Regional variation in longitudinal trajectories of primary care opioids prescribing across Health Boards in Scotland: a population-based study
  28. Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer
  29. Evaluating the direct medical cost, drug utilization and expenditure for managing Parkinson’s disease: a costing study at a medical center in China
  30. Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ
  31. Association between opioid-related deaths and prescribed opioid dose and psychotropic medicines in England: a case-crossover study
  32. Monitoring and Improving Adherence to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: A Systematic Review
  33. Association between opioid‐related deaths and persistent opioid prescribing in primary care in England: A nested case‐control study
  34. Filled prescriptions for opioids among children and adolescents – A nationwide study from 2010 to 2018
  35. Investigating the prescribing trajectory and geographical drug utilisation patterns of gabapentinoids in primary care in England: An ecological study
  36. Increasing tramadol utilisation under strict regulatory control of opioid prescribing – A cross-sectional study in Taiwan from 2002 through 2016
  37. Association of socioeconomic deprivation with opioid prescribing in primary care in England: a spatial analysis
  38. Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia
  39. Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework
  40. Supporting patients with long‐term conditions in the community: Evaluation of the Greater Manchester Community Pharmacy Care Plan Service
  41. Awareness of Antibiotic Use and Resistance in Jordanian Community
  42. Efficacy of a medication management service in improving adherence to tyrosine kinase inhibitors and clinical outcomes of patients with chronic myeloid leukaemia: a randomised controlled trial
  43. Implementation of an innovative surgical pharmacy service to improve patient outcomes—Twelve‐month outcomes of the Enhanced Surgical Medicines Optimization Service
  44. Supporting the provision of pharmacy medication reviews to marginalised (medically underserved) groups: a before/after questionnaire study investigating the impact of a patient–professional co-produced digital educational intervention
  45. Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors
  46. Prescription opioids: Regional variation and socioeconomic status – evidence from primary care in England
  47. Abstract
  48. Survivor perspectives on the role of the community pharmacist in breast cancer services
  49. Development of REACT � an on-line decision support tool for personalized cancer symptom checking in the community
  50. Development of REACT � an on-line decision support tool for personalized cancer symptom checking in the community (Preprint)
  51. A 15-year overview of increasing tramadol utilisation and associated mortality and the impact of tramadol classification in the United Kingdom
  52. Exploring factors associated with patients’ adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom
  53. Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study
  54. Supporting underserved patients with their medicines: a study protocol for a patient/professional coproduced education intervention for community pharmacy staff to improve the provision and delivery of Medicine Use Reviews (MURs)
  55. A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients
  56. The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental d...
  57. Risks of nonadherence to hormone therapy in Asian women with breast cancer
  58. Acupuncture or Low Frequency Infrared Treatment for Low Back Pain in Chinese Patients: A Discrete Choice Experiment
  59. A competing risk analysis of hormone therapy interruption in Asian women with breast cancer
  60. Changes in trends and pattern of strong opioid prescribing in primary care
  61. Interruption and Non-Adherence to Long-Term Adjuvant Hormone Therapy Is Associated with Adverse Survival Outcome of Breast Cancer Women - An Asian Population-Based Study
  62. Is It Feasible to Apply Preference-Based Quality-of-Life Measures on Patients with Chronic Myeloid Leukemia?
  63. Adherence to inhaled corticosteroids by asthmatic patients: measurement and modelling
  64. Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan
  65. Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
  66. A Systematic Review of Utility Values for Chemotherapy-Related Adverse Events
  67. Long-term efficacy and safety of exemestane in the treatment of breast cancer
  68. How Does Out-of-Pocket Payment Affect Choices When Accessing Health Care?—A Qualitative Study on Hypertensive Outpatients in Southern Taiwan
  69. Implementation of innovative pharmacogenetic tests into practice in Taiwan: an institutional perspective
  70. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan
  71. Meta-Analysis of the Efficacy and Safety of Zolmitriptan in the Acute Treatment of Migraine
  72. Topical pimecrolimus for eczema
  73. Meta-Analysis Examining the Efficacy and Safety of Almotriptan in the Acute Treatment of Migraine
  74. Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study
  75. Risk of myocardial infarction associated with selective COX-2 inhibitors: Meta-analysis of randomised controlled trials
  76. Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials
  77. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control